Breaking News Instant updates and real-time market news.

MOR

MorphoSys

$26.23

1.16 (4.63%)

09:25
06/25/19
06/25
09:25
06/25/19
09:25

MorphoSys to host analyst & investor meeting

Analyst & Investor meeting to be held in New York, NY on June 25 at 10 am. Webcast Link

  • 25

    Jun

  • 07

    Aug

MOR MorphoSys
$26.23

1.16 (4.63%)

05/16/19
PIPR
05/16/19
NO CHANGE
Target $39
PIPR
Overweight
MorphoSys L-MIND data highlight MOR-288 efficiency, says Piper Jaffray
Piper Jaffray analyst Danielle Brill kept her Overweight rating and $39 price target on MorphoSys after the company disclosed top-line data from its L-MIND trial of MOR-208 earlier this afternoon. The analyst notes that the primary endpoint was met and the collective data "look strong". Brill is maintaining her view that the FDA will be supportive of accelerated approval rate after the combination of MOR-208 +lenalidomide demonstrated an overall response rate of 60% with an "impressive" median duration of response of 21.7 months.
05/20/19
PIPR
05/20/19
NO CHANGE
Target $39
PIPR
Overweight
Piper remains bullish on MorphoSys after L-MIND data update
Piper Jaffray analyst Danielle Brill remains bullish on MOR208 following last week's L-MIND data update. The update caused significant investor debate, specifically on the median progression free survival data point for MOR208 plus Revlimid, which "dropped" from 16 months to 12 months, Brill tells investors in a research note. However, she points out that management clarified that the PFS curve, which she views to be more relevant versus a single median data point, was "superimposable" from the 12 month data. Regardless, a mPFS of 12 months is still superior to results seen with competitors in relapsed-refractory diffuse large B cell lymphoma, says the analyst. Brill continues to believe the FDA will approve MOR208 + Revlimid in 2020. She keeps an Overweight rating on MorphoSys with a $39 price target.
06/11/19
PIPR
06/11/19
NO CHANGE
Target $39
PIPR
Overweight
Roche approval has positive read through for MorphoSys, says Piper Jaffray
Roche's (RHHBY) accelerated approval of Polivy two months ahead of its FDA action date has a positive read through to MorphoSys' (MOR) MOR208, Piper Jaffray analyst Danielle Brill tells investors in a research note. While not a perfect comparison, the approval further signifies progression free survival data are not the most important efficacy measure for MOR208, adds the analyst. Further, she still thinks MOR208's efficacy and safety profile "appears distinctively better" than Polivy's. Brill remains confident for accelerated approval of MOR208 and believes that it could warrant a premium price-tag to Polivy's estimated average of $90,000 every four months. She reiterates an Overweight rating on MorphoSys shares with a $39 price target.
06/24/19
PIPR
06/24/19
NO CHANGE
PIPR
Overweight
Piper Jaffray confident in accelerated approval for MorphoSys' MOR208
After Morphosys shared more detailed results from its L-MIND study at the ICML meeting, Piper Jaffray analyst Danielle Brill said she is confident in accelerated approval for MOR208 based on the strong response rates shown throughout key subgroups and the "relatively clean" safety profile with no evidence of peripheral neuropathy. She maintains an Overweight rating on MorphoSys shares ahead of the company's planned breakfast on Tuesday to discuss the data further.

TODAY'S FREE FLY STORIES

SCBFF

Standard Chartered

$0.00

(0.00%)

13:07
07/19/19
07/19
13:07
07/19/19
13:07
Periodicals
Standard Chartered accused of handling $56.8B in illegal Iran deals, FT says »

Whistleblowers are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSIX

Power Solutions

$0.00

(0.00%)

13:06
07/19/19
07/19
13:06
07/19/19
13:06
Hot Stocks
Former Power Solutions CEO charged with accounting fraud »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$10.38

0.765 (7.96%)

13:05
07/19/19
07/19
13:05
07/19/19
13:05
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 16

    Aug

  • 05

    Sep

13:04
07/19/19
07/19
13:04
07/19/19
13:04
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 7/19 Baker-Hughes…

BHGE

Baker Hughes

$23.65

0.34 (1.46%)

13:01
07/19/19
07/19
13:01
07/19/19
13:01
Hot Stocks
Baker Hughes reports U.S. rig count down 4 to 954 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 27

    Aug

12:45
07/19/19
07/19
12:45
07/19/19
12:45
General news
Breaking General news story  »

Week of 7/19 Baker-Hughes…

LYFT

Lyft

$67.78

1.74 (2.63%)

12:43
07/19/19
07/19
12:43
07/19/19
12:43
Hot Stocks
Lyft announces new airport pickup feature starting July 20 at LGA »

In a blog post, Lyft…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

WMT

Walmart

$114.81

0.13 (0.11%)

12:41
07/19/19
07/19
12:41
07/19/19
12:41
Periodicals
Walmart to shuffle executives to further integrate stores and digital, CNBC says »

Walmart is shuffling its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 25

    Sep

  • 13

    Nov

WMT

Walmart

$114.83

0.15 (0.13%)

12:36
07/19/19
07/19
12:36
07/19/19
12:36
Periodicals
Walmart to shuffle executives to further integrate stores and digital, CNBC says »

CNBC's Courtney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 25

    Sep

  • 13

    Nov

NFLX

Netflix

$321.59

-3.55 (-1.09%)

12:29
07/19/19
07/19
12:29
07/19/19
12:29
Periodicals
Eddie Murphy in talks with Netflix over comedy specials, TMZ reports »

Comedian and actor Eddie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

FL

Foot Locker

$42.72

0.35 (0.83%)

12:25
07/19/19
07/19
12:25
07/19/19
12:25
Options
Foot Locker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

DIS

Disney

$141.00

-0.62 (-0.44%)

, SNE

Sony

$53.93

-0.02 (-0.04%)

12:21
07/19/19
07/19
12:21
07/19/19
12:21
On The Fly
Box Office Battle: 'Lion King' expected to claim this weekend's throne »

Welcome to "Box Office…

DIS

Disney

$141.00

-0.62 (-0.44%)

SNE

Sony

$53.93

-0.02 (-0.04%)

T

AT&T

$32.91

-0.185 (-0.56%)

CBS

CBS

$51.32

-0.02 (-0.04%)

CMCSA

Comcast

$44.14

-0.42 (-0.94%)

CMCSK

Comcast

$0.00

(0.00%)

LGF.A

Lionsgate

$11.72

0.14 (1.21%)

LGF.B

Lionsgate

$11.05

0.03 (0.27%)

VIA

Viacom

$35.39

0.39 (1.11%)

VIAB

Viacom

$30.79

0.2 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 30

    Jul

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

12:21
07/19/19
07/19
12:21
07/19/19
12:21
Conference/Events
Wolfe Research utilities/midstream analyst to hold a group luncheon »

Utilities & Midstream…

AMRX

Amneal Pharmaceuticals

$3.35

-0.04 (-1.18%)

, BMY

Bristol-Myers

$43.57

-0.47 (-1.07%)

12:18
07/19/19
07/19
12:18
07/19/19
12:18
Hot Stocks
Amneal Pharmaceuticals granted tentative FDA approval of Apremilast »

Amneal Pharmaceuticals…

AMRX

Amneal Pharmaceuticals

$3.35

-0.04 (-1.18%)

BMY

Bristol-Myers

$43.57

-0.47 (-1.07%)

CELG

Celgene

$90.39

-0.51 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 25

    Jul

  • 08

    Aug

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
07/19/19
07/19
12:17
07/19/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
07/19/19
07/19
12:16
07/19/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YGTY

SSLJ.com

$1.18

-0.12 (-9.23%)

12:15
07/19/19
07/19
12:15
07/19/19
12:15
Hot Stocks
Breaking Hot Stocks news story on SSLJ.com »

SSLJ com Ltd (Class A…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$374.39

13.22 (3.66%)

, MSFT

Microsoft

$138.27

1.98 (1.45%)

12:10
07/19/19
07/19
12:10
07/19/19
12:10
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are modestly…

BA

Boeing

$374.39

13.22 (3.66%)

MSFT

Microsoft

$138.27

1.98 (1.45%)

AXP

American Express

$125.00

-3.4 (-2.65%)

GCI

Gannett

$9.62

1.72 (21.77%)

CRWD

Crowdstrike

$83.30

10.55 (14.50%)

SKX

Skechers

$39.35

4.6 (13.24%)

MIK

Michaels

$7.75

-0.62 (-7.41%)

PACB

Pacific Biosciences

$5.23

-0.64 (-10.90%)

ILMN

Illumina

$291.57

-6.97 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 24

    Jul

  • 29

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 03

    Sep

  • 25

    Sep

  • 13

    Nov

CMI

Cummins

$170.04

2.08 (1.24%)

, VWAGY

Volkswagen

$0.00

(0.00%)

12:06
07/19/19
07/19
12:06
07/19/19
12:06
Periodicals
Cummins makes bid for VW's MAN Energy Solutions unit, Reuters says »

Cummins (CMI) has made an…

CMI

Cummins

$170.04

2.08 (1.24%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

SSRM

SSR Mining

$15.69

-0.04 (-0.25%)

12:05
07/19/19
07/19
12:05
07/19/19
12:05
Options
SSR Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

12:05
07/19/19
07/19
12:05
07/19/19
12:05
General news
U.S. Data Slate: The week of July 22 »

U.S. Data Slate: The week…

XOM

Exxon Mobil

$74.86

0.02 (0.03%)

12:04
07/19/19
07/19
12:04
07/19/19
12:04
Periodicals
Exxon Mobil starts process of selling Norwegian oil fields, Bloomberg says »

Exxon Mobil has begun the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

CTK

CooTek

$8.54

-0.02 (-0.23%)

12:00
07/19/19
07/19
12:00
07/19/19
12:00
Hot Stocks
CooTek falls -6.6% »

CooTek is down -6.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHWY

Chewy

$30.63

-2.16 (-6.59%)

12:00
07/19/19
07/19
12:00
07/19/19
12:00
Hot Stocks
Chewy falls -6.8% »

Chewy is down -6.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$5.29

-1.02 (-16.16%)

12:00
07/19/19
07/19
12:00
07/19/19
12:00
Hot Stocks
QEP Resources falls -16.2% »

QEP Resources is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.